OncoCyte Corporation
OncoCyte Corporation, a leading innovator in the field of cancer diagnostics, is headquartered in the United States. Founded in 2014, the company has rapidly established itself within the oncology industry, focusing on the development of advanced diagnostic tests that enhance early detection and treatment of cancer. With a strong emphasis on precision medicine, OncoCyte's core products include proprietary assays designed to identify specific cancer types, which are distinguished by their unique methodologies and high accuracy rates. The company has achieved significant milestones, including partnerships with major healthcare institutions, positioning itself as a trusted name in cancer diagnostics. OncoCyte continues to expand its operational reach, aiming to improve patient outcomes through innovative solutions in cancer care, thereby solidifying its market position as a frontrunner in the diagnostic landscape.
DitchCarbon Score
How does OncoCyte Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OncoCyte Corporation's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OncoCyte Corporation's reported carbon emissions
OncoCyte Corporation, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. In the absence of concrete data, it is important to note that many companies in the biotechnology sector are increasingly focusing on reducing their carbon footprints and committing to climate action. OncoCyte may be part of this broader industry trend, but specific details regarding their emissions or climate commitments remain unspecified.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OncoCyte Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
